MedTrace Logo

Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex

NCT01295450 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2011-02-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and tolerability of Apevinat BC compared to vitamin complex, in the treatment of lack of appetite and prevention of deficiency of B and C vitamins.

Conditions

  • Lack of Appetite
  • Anorexia

Interventions

DRUG

Apevinat BC

Apevinat BC presents in its formula the cyproheptadine hydrochloride (0,800 mg), tiamin hydrochloride(0,120 mg), Riboflavin sodium phosphate (0,200 mg), nicotinamide (1,334 mg, piridoxin hydrochloride (0,134 mg), ascorbic acid (4,334 mg). Administer the recommended dosage for children 7 to 14, preferably one hour before meals: 5 ml three times daily.

DRUG

Vitamin Complex

A vitamin complex contains: B1, B2, B3, B3 and C vitamins. Administer the recommended dosage preferably one hour before meals: 5 ml three times daily.

Sponsors & Collaborators

  • MDCPharma Produtos Farmaceuticos LTDA

    lead INDUSTRY

Principal Investigators

  • Joaquim CS D' Azevedo, Investigator · A/Z Clinical

  • Felicio S Neto, Investigator · Dr. Felicio Savioli Clinical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01295450 on ClinicalTrials.gov